Enhancing Bioactivities and Chemical Properties of A Marine Briarane-type Diterpenoid With Late-Stage Diversification

07 June 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Excavatolide B (1, ExcB), a briarane-type diterpenoid isolated from Formosan gorgonian Briareum stechei, exhibits promising anti-inflammatory activity with low cytotoxicity. In this study, we report the structure-activity relationship of ExcB derivatives with late-stage modifications around the carboframe of 1. We identified a potent analog 22 with improved in vitro inhibitory activities against the inducible nitric oxide synthase gene expression, nitric oxide production, IL-6, and TNF- production in LPS-stimulated RAW264.7 macrophages. The esterification of piperidyl with proper spacer length in analog 22 also substantially increased the aqueous solubility >100-fold. More importantly, under similar dosing regimen compared to that of parent 1, 22 in its salt form showed an 80% increase in anti-inflammatory activity to alleviate carrageenan-induced paw edema in rats. Overall, these findings would greatly facilitate the further development of more potent analogs with enhanced bioactivities and improved drug-like properties of the underexplored class of briarane-type natural diterpenoids.

Keywords

Anti-inflammation
Marine Briarane-type Diterpene
Excavatolide B
Late-stage diversification

Supplementary materials

Title
Description
Actions
Title
Enhancing Bioactivities and Chemical Properties of A Marine Briarane-type Diterpenoid with Late-Stage Diversification
Description
Water Solubility of compound 1, 22 and 22-HCl by HPLC method; X-ray crystallographic analysis; 1H and 13C NMR spectra; and HRMS spectra.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.